 OncoSec Medical Incorporated NASDAQ:ONCS the Company or OncoSec, a company developing late-stage intratumoral DNAbased cancer immunotherapies, today announced the promising potential of its novel DNAencodable vaccine candidate, CORVax12, which is designed to act as a prophylactic vaccine to prevent COVID-19, was featured in the show Straight Talk by KGW NewsChannel 8, an NBC TV affiliate in Portland, Oregon. 